Garlic as an Anti-diabetic Agent: Recent Progress and Patent Reviews

Author(s): Raju Padiya, Sanjay K. Banerjee

Journal Name: Recent Patents on Food, Nutrition & Agriculture
Continued as Recent Advances in Food, Nutrition & Agriculture

Volume 5 , Issue 2 , 2013

Become EABM
Become Reviewer
Call for Editor


This article reviews recent literature on the usage and relevance of garlic and its bioactive components in controlling diabetes and diabetes-associated pathologies; and also updates recent patents on the subject. Antidiabetic effect of garlic is well documented even in ancient medical literature. Garlic and its active ingredients have been extensively studied for their antidiabetic efficacies in either experimentally induced or genetic animal models of diabetes. Human studies are also available where hypoglycemic effect of garlic was reported. The beneficial effects of garlic are mainly attributed to the presence of volatile sulfur compounds like alliin, allicin, diallyl disulfide, diallyl trisulfide, diallyl sulfide, S-allyl cysteine, ajoene and allyl mercaptan. Garlic and garlic extracts have been shown to be effective in reducing insulin resistance. Therefore, considering the importance of garlic in controlling diabetic complications, several preparations and food processes containing garlic have been patented. This review discusses some of the recent progresses made in this field and consolidates the results.

Keywords: Allicin, Allyl mercaptan, ajoene, animal studies, diabetes, Garlic, human studies, patent, S-allyl cysteine

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 30 April, 2013
Page: [105 - 127]
Pages: 23
DOI: 10.2174/18761429113059990002
Price: $65

Article Metrics

PDF: 30